NVLPF (Nova Leap Health) Change In Receivables: $-0.10 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVLPF Nova Leap Health Corp NVLPF
50 GF Score
Price $0.26
GF Value $0.22
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Nova Leap Health Change In Receivables?

Nova Leap Health NVLPF 50 Change In Receivables is $-0.10 Mil as of Mar. 2026. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.22 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Nova Leap Health's change in receivables for the quarter that ended in Mar. 2026 was $0.01 Mil. It means Nova Leap Health's Accounts Receivable declined by $0.01 Mil from Dec. 2025 to Mar. 2026 .

Nova Leap Health's change in receivables for the fiscal year that ended in Dec. 2025 was $-0.14 Mil. It means Nova Leap Health's Accounts Receivable increased by $0.14 Mil from Dec. 2024 to Dec. 2025 .

Nova Leap Health's Accounts Receivable for the quarter that ended in Mar. 2026 was $1.82 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Nova Leap Health's Days Sales Outstanding for the three months ended in Mar. 2026 was 21.20.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Nova Leap Health's liquidation value for the three months ended in Mar. 2026 was $-1.38 Mil.

Nova Leap Health  (OTCPK:NVLPF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Nova Leap Health's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1.824/7.852*91
=21.20

2. In Ben Graham's calculation of liquidation value, Nova Leap Health's accounts receivable are only considered to be worth 75% of book value:

Nova Leap Health's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1.605-4.352+0.75 * 1.824+0.5 * 0
=-1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Leap Health Change In Receivables Related Terms

Nova Leap Health Change In Receivables Historical Data

* Premium members only.

The historical data trend for Nova Leap Health's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Leap Health Change In Receivables Chart

Nova Leap Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.76 0.42 0.10 -0.05 -0.14

Nova Leap Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.08 -0.32 0.13 0.01
NVLPF
50GF Score
Nova Leap Health Corp NVLPF
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Leap Health Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-0.10 Mil mean?
Nova Leap Health (NVLPF) has a Change In Receivables of $-0.10 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Nova Leap Health and its competitors.
Is Nova Leap Health's Change In Receivables too high?
Nova Leap Health's current Change In Receivables is $-0.10 Mil. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Change In Receivables compare to HCA and THC?
Nova Leap Health's Change In Receivables of $-0.10 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Nova Leap Health and its competitors. Nova Leap Health's current Change In Receivables is $-0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.22, compared to a current price of $0.26 — trading 18.2% above its estimated fair value. The current Change In Receivables is $-0.10 Mil. Nova Leap Health's overall GF Score™ is 50/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current Change In Receivables is $-0.10 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova Leap Health (NVLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued. The current stock price of $0.26 is trading 18.2% above its estimated GF Value™ of $0.22. GuruFocus considers Nova Leap Health to be Modestly Overvalued.

Key valuation signals for NVLPF:

  • Change In Receivables: $-0.10 Mil
  • GF Value™: $0.22 vs. price of $0.26 (18.2% above fair value)
  • GF Score™: 50/100 with 1 warning sign

No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nova Leap Health Business Description

Other Exchanges NLH:Canada
Address 7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score

Get the complete analysis for NVLPF

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price
$0.22
GF Value